Ruochan Chen Selected Research

Ruochan Chen Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 12/2014
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2016
5	Inflammation (Inflammations) 01/2022 - 11/2013
4	Hepatitis B 01/2021 - 04/2016
4	Infections 01/2021 - 04/2016
4	Carcinogenesis 01/2021 - 11/2013
2	Liver Diseases (Liver Disease) 01/2021 - 11/2013
2	Chronic Hepatitis B 01/2021 - 01/2021
2	Sepsis (Septicemia) 01/2019 - 01/2019
2	Hypoxia (Hypoxemia) 01/2018 - 01/2016
2	Pancreatitis 01/2016 - 04/2014
2	Necrosis 03/2015 - 04/2014
1	Hepatic Encephalopathy 01/2021
1	COVID-19 12/2020
1	Human Influenza (Influenza) 03/2019
1	Escherichia coli Infections 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Fibrosarcoma 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2014
1	Immune System Diseases (Immune Disorders) 12/2014
1	Communicable Diseases (Infectious Diseases) 12/2014
1	Ischemia 12/2014
1	Edema (Dropsy) 04/2014
1	Fibrosis (Cirrhosis) 11/2013
1	Autoimmune Diseases (Autoimmune Disease) 11/2013

Drug/Important Bio-Agent (IBA)

7	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2020
3	Hepatitis B e AntigensIBA 01/2021 - 04/2016
3	InflammasomesIBA 01/2019 - 01/2016
2	tenofovir alafenamideIBA 01/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2020 - 12/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 01/2016
2	CeruletideIBA 01/2016 - 04/2014
2	Arginine (L-Arginine)FDA Link 01/2016 - 04/2014
2	Nucleosomes (Nucleosome)IBA 01/2016 - 04/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 04/2014
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	FumaratesIBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Oseltamivir (Tamiflu)FDA Link 03/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2018
1	Circular RNAIBA 01/2018
1	GA-Binding Protein Transcription FactorIBA 01/2018
1	Neutralizing AntibodiesIBA 09/2016
1	Heparin (Liquaemin)FDA LinkGeneric 09/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2016
1	ChemokinesIBA 09/2016
1	Histones (Histone)IBA 09/2016
1	hepatitis B hyperimmune globulinIBA 04/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	NucleotidesIBA 04/2016
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 04/2016
1	NucleosidesIBA 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 04/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	erastinIBA 01/2016
1	Kelch-Like ECH-Associated Protein 1IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	quinone (benzoquinone)IBA 01/2016
1	Buthionine SulfoximineIBA 01/2016
1	Ferritins (Ferritin)IBA 01/2016
1	Heme Oxygenase-1IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2014
1	Amylases FDA Link 04/2014

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2018
1	Immunotherapy 01/2021